Imaging Retinal Vasculature in Infant Eyes (NCT05558059)
Elucidating Perifoveal Vasculature Development in Infants
🩺 Plain-English Summary (8th-Grade Level)
Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a critical location in the retina determining visual acuity and visual function, and the blood vessels around it, are abnormally developed in infants with retinopathy of prematurity. However, how these blood vessels form during development of the human fovea remains unclear. This research will advance our understanding of the fundamental knowledge of how the blood vessels around the fovea form in infants, and how they change in diseased states such as preterm birth or retinopathy of prematurity.
Who can join: Review the eligibility criteria below.
Location: Duke University — Durham, North Carolina
Age range: Not specified to 2 Months
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Duke University — Durham, North Carolina
- University of Pennsylvania — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (919) 684-8434
Email: xi2.chen@duke.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Retinopathy of Prematurity
- Bevacizumab Treatment For Type 1 ROP — Little Rock, Arkansas
- Validation of i-ROP DL to Detect More Than Mild ROP — Portland, Oregon
- Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next) — La Jolla, California
- Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2) — Durham, North Carolina
- Clinical and Genetic Analysis of ROP — Palo Alto, California
Explore by condition: All Retinopathy of Prematurity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.